Om

Eloxx Pharmaceuticals, Inc. is a clinical-stage biopharmaceutical company focused on developing RNA-modulating medicines for rare and ultra-rare genetic disorders caused by nonsense mutations. The company’s work centers on small-molecule product candidates designed to encourage ribosomal readthrough of premature stop codons, with the goal of helping restore production of full-length proteins. Its current pipeline includes exaluren, which is being developed for rare kidney diseases, and licensed programs such as ZKN-013 for rare skin diseases. Eloxx Pharmaceuticals concentrates on precision medicine approaches for patients with conditions that have limited treatment options, positioning the company within the specialized rare-disease segment of biotechnology. Headquartered in Arlington, Massachusetts, Eloxx Pharmaceuticals is a focused research-driven company operating at the intersection of molecular biology, drug development, and orphan disease therapeutics.

Markedsdata leveret af TwelveData og Morningstar

Aktiemarkedet kan gå både op og ned. Selvom investeringer i aktier historisk set har givet investorer et positivt afkast på langt sigt, er der ingen garanti for fremtidige afkast. Der er derfor en risiko for, at du ikke får de investerede penge tilbage.

INVESTER I ELOXX PHARMACEUTICALS MED ENDAVU: Køb Eloxx Pharmaceuticals ($ELOX) aktier gennem Endavu’s investeringsplatform. Hos Endavu kan du købe og sælge aktier i Eloxx Pharmaceuticals, og handle med aktier, fraktionaler, ETF'er og andre finansielle instrumenter. Endavu tilbyder handel uden kurtage på amerikanske aktier. Endavu tilbyder lav kurtage på tværs af aktier. Handl med over 30.000 forskellige aktier og udenfor markedsåbningstider.